Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?

Aliment Pharmacol Ther. 2016 May;43(9):1021-2. doi: 10.1111/apt.13574.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bilirubin*
  • Gilbert Disease*
  • Hepatitis C, Chronic / drug therapy
  • Humans
  • Liver Cirrhosis / drug therapy
  • Ribavirin / therapeutic use

Substances

  • Ribavirin
  • Bilirubin